Visit us and request a demonstration of the Inspirio® pump to discover how its design can help simplify treatment administration in everyday clinical practice.
Inspirio® complies with current regulations regarding medical devices.
Are you a healthcare professional?
According to current legislation, the information you need to see is considered information aimed exclusively at the health professional.
Ferrer booth
Ferrer Symposium
Meet the Expert sessions
Our team will be on hand for scientific conversations, live Inspirio® pump demonstrations and one-on-one educational interactions with experts.
Visit us at Booth M.01 in Hall 2, Fira Barcelona Gran Via, during the ERS International Congress 2026.
Visit us and request a demonstration of the Inspirio® pump to discover how its design can help simplify treatment administration in everyday clinical practice.
Inspirio® complies with current regulations regarding medical devices.
This scientific symposium will present the final results of the Phase 3 TETON clinical program, explore new frontiers in the treatment of IPF, and examine the mechanistic rationale for inhaled therapy. Join leading international experts for a comprehensive review of the evidence shaping the future of idiopathic pulmonary fibrosis management.
Get to know the symposium faculty bringing clinical insight and scientific expertise to rare pulmonary diseases.
MD, PhD - Chairperson (Spain)
MD, PhD - Chairperson (Netherlands)
MD - Speaker (USA)
MD, PhD - Speaker (France)
For any medical or scientific information requests, please contact our Medical Information team through the following link:
Stay up to date with clinical research, medical education, congress highlights, and Ferrer publications. Tell us which ERS 2026 topics interest you.
At Ferrer we use business to fight for social justice because we believe everyone has the right to live with dignity, and that companies have a responsibility to help create the conditions that make that possible.
Our scientific focus is an expression of our purpose. We choose to focus on rare diseases and areas of high unmet need because we believe no one should be left behind simply because their condition is rare, complex or difficult to treat.